These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10688605

  • 1. c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity.
    Arora V, Knapp DC, Smith BL, Statdfield ML, Stein DA, Reddy MT, Weller DD, Iversen PL.
    J Pharmacol Exp Ther; 2000 Mar; 292(3):921-8. PubMed ID: 10688605
    [Abstract] [Full Text] [Related]

  • 2. Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo.
    Arora V, Iversen PL.
    Drug Metab Dispos; 2000 Feb; 28(2):131-8. PubMed ID: 10640509
    [Abstract] [Full Text] [Related]

  • 3. Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats.
    Arora V, Knapp DC, Reddy MT, Weller DD, Iversen PL.
    J Pharm Sci; 2002 Apr; 91(4):1009-18. PubMed ID: 11948540
    [Abstract] [Full Text] [Related]

  • 4. Manipulation of metallothionein expression in the regenerating rat liver using antisense oligonucleotides.
    Arora V, Iversen PL, Ebadi M.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):711-8. PubMed ID: 9618277
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the rat cytochrome P450 3A2 by an antisense phosphorothioate oligodeoxynucleotide in vivo.
    Desjardins JP, Iversen PL.
    J Pharmacol Exp Ther; 1995 Dec 29; 275(3):1608-13. PubMed ID: 8531135
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR.
    Clin Cancer Res; 2003 Jul 29; 9(7):2510-9. PubMed ID: 12855625
    [Abstract] [Full Text] [Related]

  • 7. Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology.
    Mahadevan B, Arora V, Schild LJ, Keshava C, Cate ML, Iversen PL, Poirier MC, Weston A, Pereira C, Baird WM.
    Mol Carcinog; 2006 Feb 29; 45(2):118-25. PubMed ID: 16329150
    [Abstract] [Full Text] [Related]

  • 8. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
    Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR.
    Lung Cancer; 2008 Jun 29; 60(3):347-54. PubMed ID: 18096271
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of in vivo rat liver regeneration by 2-acetylaminofluorene affects the regulation of cell cycle-related proteins.
    Ohlson LC, Koroxenidou L, Hällström IP.
    Hepatology; 1998 Mar 29; 27(3):691-6. PubMed ID: 9500696
    [Abstract] [Full Text] [Related]

  • 10. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
    Cho IJ, Sung DK, Kang KW, Kim SG.
    Arch Pharm Res; 2009 Apr 29; 32(4):625-35. PubMed ID: 19407981
    [Abstract] [Full Text] [Related]

  • 11. Posttranscriptional regulation of cyclin B messenger RNA expression in the regenerating rat liver.
    Trembley JH, Kren BT, Steer CJ.
    Cell Growth Differ; 1994 Jan 29; 5(1):99-108. PubMed ID: 8123599
    [Abstract] [Full Text] [Related]

  • 12. The delay in rat liver regeneration by choline is associated to alteration in c-myc expression.
    Sesca E, Chiara M, Binasco V, Tessitore L.
    Boll Soc Ital Biol Sper; 1996 Jan 29; 72(7-8):217-22. PubMed ID: 9009061
    [Abstract] [Full Text] [Related]

  • 13. Relationship between expression of cyclin D1 and impaired liver regeneration observed in fibrotic or cirrhotic rats.
    Kato A, Bamba H, Shinohara M, Yamauchi A, Ota S, Kawamoto C, Yoshida Y.
    J Gastroenterol Hepatol; 2005 Aug 29; 20(8):1198-205. PubMed ID: 16048567
    [Abstract] [Full Text] [Related]

  • 14. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T, Rodriguez ME, Tacke F, Xiong Y, Brenner DA, Trautwein C.
    Hepatology; 2003 Apr 29; 37(4):833-41. PubMed ID: 12668976
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis induced by 5-(N,N-hexamethylene)-amiloride in regenerating liver after partial hepatectomy.
    Suzuki T, Tsukamoto I.
    Eur J Pharmacol; 2004 Oct 25; 503(1-3):1-7. PubMed ID: 15496288
    [Abstract] [Full Text] [Related]

  • 16. Inhibited activities in CCAAT/enhancer-binding protein, activating protein-1 and cyclins after hepatectomy in rats with thioacetamide-induced liver cirrhosis.
    Zhao G, Nakano K, Chijiiwa K, Ueda J, Tanaka M.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):474-81. PubMed ID: 11906187
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
    Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, Pascale RM.
    Carcinogenesis; 2004 Mar 29; 25(3):333-41. PubMed ID: 14604889
    [Abstract] [Full Text] [Related]

  • 18. In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.
    Devi GR, Beer TM, Corless CL, Arora V, Weller DL, Iversen PL.
    Clin Cancer Res; 2005 May 15; 11(10):3930-8. PubMed ID: 15897595
    [Abstract] [Full Text] [Related]

  • 19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 20. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N.
    J Gastroenterol Hepatol; 2008 Jun 15; 23(6):930-7. PubMed ID: 18565023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.